SHARPS TECHNOLOGY INC (STSS) Stock Price & Overview
NASDAQ:STSS • US82003F3091
Current stock price
The current stock price of STSS is 1.69 USD. Today STSS is up by 0.6%. In the past month the price decreased by -5.62%. In the past year, price decreased by -78.29%.
STSS Key Statistics
- Market Cap
- 49.01M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -689.83
- Dividend Yield
- N/A
STSS Stock Performance
STSS Stock Chart
STSS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to STSS. When comparing the yearly performance of all stocks, STSS is a bad performer in the overall market: 95.28% of all stocks are doing better.
STSS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to STSS. STSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
STSS Earnings
STSS Forecast & Estimates
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 1227.81% is expected in the next year compared to the current price of 1.69.
For the next year, analysts expect an EPS growth of -633.33% and a revenue growth -95.06% for STSS
STSS Groups
Sector & Classification
STSS Financial Highlights
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -689.83. The EPS increased by 72.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.51% | ||
| ROE | -24.09% | ||
| Debt/Equity | 0.02 |
STSS Ownership
STSS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.53 | 58.459B | ||
| COO | COOPER COS INC/THE | 14.35 | 13.95B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.35 | 12.22B | ||
| SOLV | SOLVENTUM CORP | 10.01 | 11.329B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.16 | 4.901B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.84 | 4.097B | ||
| ICUI | ICU MEDICAL INC | 15.34 | 3.189B | ||
| HAE | HAEMONETICS CORP/MASS | 10.57 | 2.619B | ||
| XRAY | DENTSPLY SIRONA INC | 8.1 | 2.317B | ||
| NEOG | NEOGEN CORP | 27.94 | 2.021B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.38 | 1.493B | ||
| STAA | STAAR SURGICAL CO | 135.7 | 925.837M | ||
| BVS | BIOVENTUS INC - A | 11.88 | 759.159M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STSS
Company Profile
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Company Info
IPO: 2022-04-14
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 5
Phone: 15162464000
SHARPS TECHNOLOGY INC / STSS FAQ
What does STSS do?
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
What is the stock price of SHARPS TECHNOLOGY INC today?
The current stock price of STSS is 1.69 USD. The price increased by 0.6% in the last trading session.
Does SHARPS TECHNOLOGY INC pay dividends?
STSS does not pay a dividend.
What is the ChartMill technical and fundamental rating of STSS stock?
STSS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists STSS stock?
STSS stock is listed on the Nasdaq exchange.
What is the expected growth for STSS stock?
The Revenue of SHARPS TECHNOLOGY INC (STSS) is expected to decline by -95.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the Short Interest ratio of SHARPS TECHNOLOGY INC (STSS) stock?
The outstanding short interest for SHARPS TECHNOLOGY INC (STSS) is 2.03% of its float.